ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02788175
Brief Title: Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption

First Submitted : May 28, 2016
First Submitted that Met QC Criteria : May 28, 2016
First Posted : June 2, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 12, 2019
Last Update Posted : January 15, 2019